Advisor Group Holdings, Inc. Esperion Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 76,939 shares of ESPR stock, worth $75,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares

76,939

Previous 14,895 416.54%

Holding current value

$75,400

Previous $32,000 243.75%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$1.44 - $2.34 $89,343 - $145,182	62,044 Added 416.54%	76,939 $110,000
Q4 2024 Feb 07, 2025	SELL	$1.61 - $3.83 $99,393 - $236,445	-61,735 Reduced 80.56%	14,895 $32,000
Q3 2024 Nov 13, 2024	SELL	$1.61 - $2.73 $9,579 - $16,243	-5,950 Reduced 7.21%	76,630 $126,000
Q2 2024 Aug 13, 2024	BUY	$1.84 - $3.24 $7,268 - $12,798	3,950 Added 5.02%	82,580 $183,000
Q1 2024 May 10, 2024	BUY	$2.02 - $3.02 $13,202 - $19,738	6,536 Added 9.07%	78,630 $210,000
Q4 2023 Feb 12, 2024	BUY	$0.73 - $3.08 $530 - $2,239	727 Added 1.02%	72,094 $215,000
Q3 2023 Nov 13, 2023	BUY	$0.96 - $1.79 $6,466 - $12,057	6,736 Added 10.42%	71,367 $69,000
Q2 2023 Aug 10, 2023	BUY	$1.2 - $1.76 $5,649 - $8,286	4,708 Added 7.86%	64,631 $89,000
Q1 2023 May 12, 2023	BUY	$1.46 - $7.3 $1,896 - $9,482	1,299 Added 2.22%	59,923 $95,000
Q4 2022 Feb 10, 2023	BUY	$5.09 - $8.5 $263,667 - $440,308	51,801 Added 759.21%	58,624 $365,000
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $17,658 - $26,341	3,240 Added 90.43%	6,823 $47,000
Q2 2022 Aug 10, 2022	BUY	$4.77 - $6.67 $295 - $413	62 Added 1.76%	3,583 $24,000
Q1 2022 May 04, 2022	BUY	$3.34 - $5.56 $190 - $316	57 Added 1.65%	3,521 $16,000
Q2 2021 Aug 02, 2021	SELL	$19.4 - $28.71 $1,842 - $2,727	-95 Reduced 2.67%	3,464 $73,000
Q1 2021 May 13, 2021	SELL	$25.12 - $36.89 $9,721 - $14,276	-387 Reduced 9.81%	3,559 $99,000
Q4 2020 Feb 10, 2021	SELL	$24.2 - $35.76 $123,565 - $182,590	-5,106 Reduced 56.41%	3,946 $102,000
Q3 2020 Nov 12, 2020	SELL	$31.18 - $52.71 $36,948 - $62,461	-1,185 Reduced 11.58%	9,052 $404,000
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $53,621 - $91,588	1,785 Added 21.12%	10,237 $526,000
Q1 2020 May 18, 2020	BUY	$27.44 - $73.84 $231,922 - $624,095	8,452 New	8,452 $270,000

Others Institutions Holding ESPR

# of Institutions

200

Shares Held

119M

Call Options Held

171K

Put Options Held

679K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $65.2M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Esperion Therapeutics, Inc. Transaction History